Direxion Daily Pharmaceutical & Medical Bull 3X ETF
PILL
6 hedge funds and large institutions have $1.39M invested in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.
19,711% more capital invested
Capital invested by funds: $7.03K → $1.39M (+$1.38M)
100% more funds holding
Funds holding: 3 → 6 (+3)
11.28% more ownership
Funds ownership: 0.06% → 11.34% (+11%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$814K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$546K |
| 3 |
Belvedere Trading
Chicago,
Illinois
|
+$75.1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$7.51K |
| 5 |
Morgan Stanley
New York
|
+$449 |
Top Sellers
PILL Hedge Fund Activity: Q1 2025 in Review
6 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) for Q1 2025, worth a combined $1.39M — up 19,711% from $7.03K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new PILL positions and 0 closed out — a net gain of 4 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Tower Research Capital (TRC), opening a new position worth an estimated $814K.
- 6 institutional investors held Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) as of Q1 2025, up from 3 in Q4 2024.
- Funds reported $1.39M of Direxion Daily Pharmaceutical & Medical Bull 3X ETF stock for Q1 2025, up 19,711% quarter-over-quarter.
- 4 funds opened new Direxion Daily Pharmaceutical & Medical Bull 3X ETF positions in Q1 2025 and 0 closed out, a net change of +4 holders.
- The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF buyer in Q1 2025 was Tower Research Capital (TRC), an estimated $814K added.
Based on aggregated 13F filings for Q1 2025.